Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bazelet Poland is the Polish subsidiary of the Bazelet Group, Israel's largest medical cannabis company. The company specializes in the research, development, and manufacturing of standardized medical cannabis products, including oils and flowers. Bazelet is recognized for its proprietary terpene-enrichment technology, which allows for the creation of condition-specific formulations tailored for indications such as chronic pain, autism, and geriatric care. The Polish entity serves as a strategic hub for distribution and market access within the European Union, leveraging the parent company's extensive clinical data and GMP-certified manufacturing capabilities. Their products are designed to provide consistent therapeutic effects through precise cannabinoid and terpene ratios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bazelet Poland.